anthropogen
driver
includ
climat
chang
exploit
natur
resourc
global
travel
promot
constant
emerg
novel
pathogen
human
popul
emerg
viral
infect
associ
signific
morbid
mortal
instanc
outbreak
subsequ
spread
new
bunyaviru
sever
fever
thrombocytopenia
syndrom
viru
sftsv
china
associ
case
casefat
rate
moreov
sft
case
recent
also
report
asian
countri
includ
south
korea
japan
similarli
first
outbreak
ebola
viru
diseas
west
africa
unfold
epidem
death
almost
case
present
approv
antivir
drug
sftsv
ebov
sever
emerg
virus
target
host
cell
factor
requir
spread
virus
dispens
cellular
surviv
consid
promis
approach
antivir
therapi
sinc
respect
drug
might
exert
broad
antivir
activ
case
sever
virus
depend
factor
might
associ
high
barrier
resist
develop
glycoprotein
envelop
virus
facilit
viral
entri
host
cell
bind
host
cell
receptor
fuse
viral
membran
cellular
membran
allow
deliveri
viral
genet
inform
host
cell
cytoplasm
howev
viral
glycoprotein
synthes
inact
precursor
depend
prime
host
cell
proteas
transit
activ
form
prime
occur
differ
cellular
local
instanc
constitut
secretori
pathway
plasma
membran
extracellular
space
proceed
differ
stage
viral
spread
includ
glycoprotein
biogenesi
infect
cell
particl
releas
infect
cell
entri
new
target
cell
similarli
differ
host
cell
proteas
hijack
virus
prime
instanc
serin
proteas
proprotein
convertas
use
lassa
viru
lasv
human
immunodefici
viru
hiv
type
ii
transmembran
serin
proteas
use
influenza
virus
coronavirus
endolysosom
cystein
proteas
cathepsin
b
cathepsin
l
catbcatl
use
ebola
viru
ebov
middl
east
respiratori
syndrom
coronaviru
merscov
sever
acut
respiratori
syndrom
coronaviru
sarscov
thu
activ
host
cell
proteas
requir
prime
viral
glycoprotein
viral
infect
respons
enzym
constitut
potenti
target
antivir
intervent
order
bunyaviral
compris
agent
sever
consid
emerg
highli
pathogen
glycoprotein
precursor
term
gngc
bunyavirus
process
signal
peptidas
endoplasm
reticulum
infect
cell
addit
crimean
congo
hemorrhag
fever
viru
gngc
process
proprotein
convertas
recent
shi
colleagu
report
gngc
bunyamwera
viru
also
process
signal
peptid
peptidas
spp
intramembran
aspartyl
proteas
cleav
membran
associ
signal
peptid
follow
liber
nascent
protein
signal
peptidas
investig
whether
spp
activ
also
requir
sftsvgngc
transit
activ
state
report
inhibit
spp
activ
interfer
sftsv
gn
gcdriven
host
cell
entri
counterintuit
block
entri
driven
ebov
glycoprotein
gp
furthermor
show
spp
inhibitor
block
ebovgpdriven
entri
interf
catb
activ
inhibitor
block
entri
alter
cellular
local
catb
bunyamwera
orthobunyaviru
gngc
shown
process
spp
therefor
investig
whether
spp
also
involv
process
gngc
highli
pathogen
sftsv
use
rhabdovir
pseudotyp
bear
sftsvgngc
spp
inhibitor
zll
keton
neg
control
employ
inhibitor
sinc
shown
involv
sftsv
gngc
process
contrast
process
lassa
viru
glycoprotein
precursor
lasvgpc
infect
cell
process
essenti
viral
infect
therefor
lasvgpc
bear
pseudotyp
includ
control
inhibitori
activ
studi
final
includ
rhabdovir
pseudotyp
bear
vesicular
stomat
viru
glycoprotein
vsvg
ebola
viru
glycoprotein
ebovgp
analys
sinc
process
glycoprotein
entri
driven
glycoprotein
independ
spp
activ
host
cell
proteas
process
viral
glycoprotein
infect
cell
viral
entri
target
cell
order
mimic
glycoprotein
process
infect
cell
produc
sftsvgngc
vsvg
lasvgpc
ebovgp
bear
pseudotyp
presenc
absenc
noncytotox
concentr
spp
inhibitor
found
infect
vsvg
bear
pseudotyp
markedli
modul
spp
inhibitor
expect
although
slight
reduct
infect
observ
presenc
inhibitor
fig
similarli
spp
inhibitor
appreci
modul
infect
sftsvgngc
pseudotyp
fig
contrast
inhibitor
markedli
reduc
infect
lasvgpcbear
pseudotyp
spp
inhibitor
modest
effect
final
surpris
infect
ebovgpbear
pseudotyp
markedli
reduc
spp
inhibitor
fig
order
mimic
glycoprotein
process
viral
entri
target
cell
preincub
spp
inhibitor
addit
pseudotyp
mark
effect
observ
vsvg
sftsvgngcbear
pseudotyp
modest
inhibit
lasvgpcdriven
entri
observ
fig
contrast
preincub
target
cell
spp
inhibitor
strongli
reduc
ebovgpdriven
entri
fig
notabl
profound
inhibit
ebovgpmedi
entri
observ
target
cell
preincub
spp
inhibitor
compar
incub
particl
produc
cell
fig
thu
spp
inhibitor
might
mainli
exert
antivir
activ
ebovgpdriven
entri
collect
result
indic
activ
spp
infect
cell
target
cell
may
requir
sftsv
vsv
infecti
entri
moreov
result
agre
find
lasvgpc
process
infect
cell
requir
viral
infect
final
result
suggest
activ
spp
relat
proteas
sensit
spp
inhibitor
might
requir
ebovgpdriven
host
cell
entri
next
explor
whether
inhibitori
effect
spp
inhibitor
ebovgpdriven
entri
concentr
depend
also
observ
glycoprotein
virus
filovirida
famili
moreov
investig
whether
earli
late
step
entri
process
block
preincub
target
cell
spp
inhibitor
reduc
ebovgpdriven
entri
concentrationdepend
fashion
littl
effect
entri
driven
lasvgpc
vsvg
fig
moreov
exposur
target
cell
spp
inhibitor
reduc
transduct
mediat
glycoprotein
ebov
respons
west
african
ebola
viru
diseas
epidem
ebov
glycoprotein
ebolaviru
speci
fig
inhibit
entri
driven
glycoprotein
lloviu
viru
llov
member
cuevaviru
genu
within
filovirida
famili
also
observ
fig
contrast
entri
driven
glycoprotein
marburg
viru
marv
modestli
inhibit
final
timeofaddit
experi
reveal
spp
inhibitor
effici
block
ebovgp
lasvgpc
vsvgdriven
entri
ad
target
cell
exposur
pseudotyp
start
lose
inhibitori
activ
ad
h
addit
pseudotyp
fig
collect
result
show
spp
inhibitor
block
host
cell
entri
driven
filoviru
glycoprotein
moreov
suggest
process
entri
cascad
block
commenc
roughli
h
viru
bind
cell
cellular
proteas
catb
catl
process
ebovgp
late
endosomeslysosom
therebi
allow
gp
bind
intracellular
receptor
essenti
infecti
viral
entri
infer
previou
work
process
gp
catbcatl
might
occur
roughli
one
hour
viru
bind
target
cell
suggest
spp
inhibitor
might
block
process
therebi
inhibit
ebovgpmedi
entri
order
explor
possibl
investig
whether
spp
inhibitor
block
cellular
entri
driven
spike
protein
merscov
sarscov
merss
sarss
also
depend
catl
activ
cell
type
spp
inhibitor
modest
effect
vsvgdriven
entri
inhibit
merss
sarssdriven
entri
effici
timeofaddit
analysi
reveal
earli
step
entri
process
block
fig
like
proteolyt
prime
protein
result
far
suggest
spp
inhibitor
might
block
ebovgpmedi
entri
inhibit
gp
process
catb
catl
next
investig
whether
spp
inhibitor
inde
interfer
proteolyt
activ
catl
catb
employ
commerci
assay
system
measur
process
model
substrat
recombin
catb
catl
respect
inhibitor
appreci
effect
catb
catl
activ
fig
abrog
inhibitor
includ
posit
control
assay
system
contrast
spp
inhibitor
abolish
catl
activ
entir
decreas
catb
activ
concentr
depend
fashion
fig
result
indic
spp
inhibitor
block
ebovgpmedi
entri
directli
interf
catbcatl
activ
found
inhibitor
block
ebovgpdriven
entri
like
stage
proteolyt
prime
gp
catbcatl
without
interf
activ
proteas
order
elucid
mechan
underli
inhibit
first
ask
whether
inhibitor
interfer
convers
catbcatl
proenzym
catalyt
activ
singl
doubl
chain
form
use
cell
transfect
express
catbcatl
immunoblot
analysi
cell
reveal
three
promin
band
rang
kda
faint
band
approxim
kda
like
repres
proform
process
intermedi
glycoform
singl
chain
form
heavi
chain
part
doubl
chain
form
fig
incub
catbcatl
transfect
cell
inhibitor
final
concentr
h
inhibit
process
catb
catl
proform
enzymat
activ
form
thu
product
catbcatl
singl
chain
form
inhibit
case
catl
also
gener
heavi
chain
part
doubl
chain
form
block
signal
observ
catb
heavi
chain
part
doubl
chain
form
faint
allow
interpret
fig
contrast
spp
inhibitor
reduc
product
enzymat
activ
form
catbcatl
condit
gener
reduc
catb
express
test
highest
concentr
fig
convers
catbcatl
proenzym
activ
form
occur
lysosom
therefor
ask
whether
inhibitor
alter
cellular
local
catbcatl
cell
cotransfect
plasmid
encod
cellular
protein
known
resid
late
endosomelysosom
compart
either
catb
catl
subsequ
treat
inhibitor
spp
inhibitor
dmso
control
extens
coloc
catb
lesser
degre
catl
observ
fig
agreement
publish
data
notabl
inhibitor
treatment
markedli
disrupt
coloc
catb
fig
fig
spp
inhibitor
moder
still
statist
signific
effect
fig
contrast
none
inhibitor
interf
coloc
catl
fig
fig
unexpectedli
spp
inhibitor
reduc
coloc
fig
fig
although
confirmatori
experi
endogen
express
protein
pend
result
suggest
inhibitor
block
ebovgpdriven
entri
reduc
catb
local
late
endosomeslysosom
site
ebovgpdriven
membran
fusion
inhibit
host
cell
proteas
respons
process
viral
glycoprotein
attract
approach
antivir
therapi
inhibitor
might
particularli
use
treatment
emerg
highli
pathogen
virus
antivir
option
avail
result
show
inhibitor
host
cell
proteas
spp
impact
sftsv
gn
gcdriven
entri
block
entri
mediat
ebovgp
moreov
demonstr
spp
inhibitor
block
enzymat
activ
ebovgp
process
host
cell
proteas
catbcatl
inhibitor
interfer
local
catb
late
endosomeslysosom
site
ebovgp
process
result
show
inhibit
block
ebovgpdriven
entri
also
indic
inhibitor
viral
glycoprotein
process
host
cell
proteas
interfer
viral
entri
direct
indirect
manner
previous
provid
evid
product
matur
sftsv
gc
protein
requir
process
gngc
precursor
intern
signal
peptid
sequenc
locat
nterminu
matur
gc
shi
colleagu
demonstr
process
gngc
anoth
bunyaviru
bunyamwera
orthobunyaviru
depend
activ
spp
thu
spp
process
nsm
part
bunyamwera
orthobunyaviru
gngc
process
requir
fusion
infect
cell
uninfect
cell
bunyavirus
like
sftsv
possess
intern
nsm
gn
gc
one
may
specul
spp
process
ctermin
portion
matur
gn
protein
remain
membran
separ
gn
gc
signal
peptidasemedi
cleavag
trigger
us
investig
whether
spp
also
requir
product
function
sftsv
gn
gc
ie
gn
gc
capabl
mediat
host
cell
entri
includ
inhibitor
studi
sinc
previous
report
compound
interfer
sftvgngc
matur
function
although
well
known
block
lasvgpc
process
viral
infect
final
examin
ebovgpdriven
entri
studi
sinc
entri
driven
glycoprotein
independ
spp
activ
depend
gp
process
catbcatl
unexpectedli
found
spp
inhibitor
block
ebovgp
sftsv
gn
gcdriven
entri
rais
question
regard
underli
mechan
timeofaddit
experi
reveal
spp
inhibitor
block
process
start
approxim
one
hour
addit
viru
cell
coincid
time
point
previous
determin
transport
ebovgpbear
particl
compart
express
high
level
gp
process
proteas
catbcatl
subsequ
sever
line
evid
obtain
support
concept
spp
inhibitor
block
ebovgpdriven
entri
inhibit
catbcatl
first
sarss
merssdriven
entri
known
depend
catl
activ
condit
examin
block
spp
inhibitor
second
direct
express
process
sarss
merss
cell
surfac
render
sarss
merssmedi
entri
catlindepend
also
abrog
entri
blockad
instal
spp
inhibitor
shown
third
entri
driven
glycoprotein
lloviu
viru
ebolavirus
test
known
depend
catbcatl
activ
although
differ
extend
also
block
spp
inhibitor
fourth
marvgpmedi
entri
rel
catbcatlindepend
effici
block
catbcatl
inhibitor
direct
evid
spp
inhibitor
interf
catbcatl
activ
obtain
examin
cleavag
artifici
substrat
use
commerci
assay
system
result
show
spp
inhibitor
block
activ
recombin
catb
catl
cystein
proteas
find
contrast
commerci
sourc
offer
zll
keton
spp
specif
inhibitor
howev
zll
keton
origin
describ
novel
cystein
proteas
inhibitor
subsequ
experi
reveal
inhibit
spp
presenilintyp
aspartyl
proteas
thu
conceiv
result
obtain
within
previou
studi
examin
spp
activ
use
zll
keton
specif
spp
inhibitor
might
need
reinterpret
inhibitor
interfer
activ
recombin
catbcatl
suggest
compound
might
block
ebovgp
process
proteas
indirect
fashion
play
central
role
cholesterol
metabol
sinc
cleav
therebi
activ
sterol
regulatori
element
bind
protein
srebp
turn
control
express
sever
enzym
intim
involv
cholesterol
synthesi
thu
inhibitor
might
interfer
ebovgpdriven
entri
modul
cholesterol
homeostasi
howev
addit
cholesterol
rescu
ebovgpdriven
blockad
inhibitor
shown
keep
recent
find
inhibit
cholesterol
synthesi
interfer
gpdriven
entri
block
gp
glycan
matur
apart
role
cholesterol
metabol
respons
gener
enzymat
activ
gnptab
precursor
protein
matur
turn
requir
gener
nglycan
mannos
phosphat
residu
serv
lysosom
target
signal
catbcatl
mani
cellular
protein
rais
question
whether
blockad
activ
might
result
misloc
catb
scenario
could
explain
inhibitor
block
catb
process
known
occur
lysosom
requir
enzymat
activ
well
ebovgpdriven
entri
confoc
microscopi
inde
reveal
inhibitor
treatment
reduc
coloc
catb
protein
target
endosomallysosom
membran
independ
pathway
thu
like
inhibit
ebovgpmedi
entri
reduc
amount
catb
late
endosomeslysosom
site
gp
prime
scenario
agreement
recent
studi
flint
colleagu
report
gnptab
express
requir
product
enzymat
activ
catb
ebovgpdriven
host
cell
entri
observ
inhibitor
block
process
catb
catl
consist
studi
flint
cowork
light
find
would
expect
inhibitor
interfer
lysosom
local
catb
catl
alter
lysosom
local
catl
detect
howev
catl
coloc
lysosom
marker
untreat
cell
alreadi
lower
measur
catb
compar
pcc
valu
fig
keep
publish
data
assay
might
sensit
enough
detect
disrupt
coloc
inhibitor
noteworthi
minor
statist
signific
reduct
coloc
also
observ
upon
treatment
cell
spp
inhibitor
inhibitor
also
markedli
interf
coloc
reason
effect
present
unknown
howev
note
spp
homologu
also
sensit
spp
inhibitor
zll
keton
local
membran
late
endosom
lysosom
moreov
shown
lack
activ
disturb
endosom
membran
traffick
morpholog
might
explain
reduc
coloc
catb
presenc
spp
inhibitor
futur
studi
reveal
whether
blockad
catbcatl
activ
spp
inhibitor
account
reduc
coloc
sinc
might
impact
interpret
result
obtain
upon
analysi
ebov
entri
presenc
catbcatl
inhibitor
collect
result
confirm
host
cell
proteas
prime
viral
glycoprotein
potenti
target
antivir
intervent
howev
also
underlin
highli
specif
inhibitor
need
order
avoid
pleiotrop
effect
final
find
previou
studi
show
interfer
activ
cellular
proteas
might
impact
avail
host
factor
requir
viru
infect
vice
versa
human
embryon
kidney
cell
african
green
monkey
kidney
cell
african
green
monkey
vero
kidney
cell
maintain
dulbecco
modifi
eagl
medium
dmem
pan
biotech
supplement
fetal
bovin
serum
fb
biochrom
uml
penicillin
streptomycin
pan
biotech
lglutamin
pan
biotech
cell
grown
humidifi
atmospher
express
plasmid
encod
glycoprotein
ebovgp
ebov
outbreak
democrat
republ
congo
mayinga
variant
genbank
access
number
ebov
ebola
west
african
evd
epidem
makona
variant
genbank
access
number
lasvgpc
merss
sarss
isol
vsvg
llovgp
marvgp
gp
ebolavirus
describ
previous
similarli
express
plasmid
encod
sarscov
receptor
merscov
receptor
ebov
receptor
also
describ
code
sequenc
catb
genbank
access
homo
sapien
cathepsin
b
ctsb
transcript
variant
mrna
carri
silent
mutat
nt
catl
genbank
access
number
homo
sapien
cathepsin
l
ctsl
transcript
variant
mrna
rtpcr
amplifi
total
rna
cell
insert
plasmid
pcagg
clone
obtain
addgen
publish
insert
vector
agei
result
plasmid
next
sequenc
insert
via
ecori
bamhi
ident
pcr
amplifi
sequenc
verifi
autom
sequenc
analysi
inhibit
cellular
proteas
inhibitor
dihydrochlorid
sigmaaldrich
taufenkirchen
germani
spp
inhibitor
zll
keton
merck
kgaa
darmstadt
germani
use
inhibitor
dilut
dmso
recommend
manufactur
cytotox
assay
promega
madison
usa
perform
confirm
inhibitor
concentr
use
affect
cell
viabil
product
rhabdovir
pseudotyp
describ
previous
briefli
human
embryon
kidney
cell
seed
cell
cultur
flask
cellsflask
calciumphosphatetransfect
glycoprotein
express
plasmid
interest
h
incub
period
cell
wash
twice
pb
fresh
cultur
medium
either
proteas
inhibitor
inhibitor
spp
inhibitor
zll
keton
dmso
ad
h
post
transfect
cell
transduc
moi
replicationdefect
vesicular
stomat
viru
pseudotyp
vsvg
encod
luciferas
green
fluoresc
protein
gfp
h
cell
wash
three
time
pb
fresh
cultur
medium
ad
contain
dilut
antivsvg
mous
hybridoma
supernat
american
type
cultur
collect
neutral
remain
vsv
activ
well
fresh
proteas
inhibitor
dmso
twentyfour
hour
post
transduct
rhabdovir
pseudotyp
harvest
cultur
supernat
via
sterilefiltr
filter
store
use
order
investig
inhibit
catb
catl
process
spp
inhibitor
cell
transfect
catb
catl
express
plasmid
incub
inhibitor
h
h
harvest
thereaft
cell
lyse
sodium
dodecyl
sulfat
sd
load
buffer
catbcatl
express
analyz
immunoblot
use
previous
describ
protocol
detect
catb
express
mous
monoclon
antibodi
rais
catb
purifi
human
liver
abcam
use
dilut
detect
catl
express
rabbit
polyclon
serum
rais
catl
amino
acid
abcam
use
dilut
detect
bound
antibodi
achiev
use
horseradish
peroxidas
coupl
goat
antimous
goat
antirabbit
secondari
antibodi
dianova
dilut
final
express
detect
use
rabbit
polyclon
serum
sigma
aldrich
dilut
infect
rhabdovir
pseudotyp
presenc
absenc
inhibitor
measur
transduct
cell
seed
plate
cellswel
h
post
seed
cell
incub
pseudotyp
viru
h
subsequ
treat
proteas
inhibitor
indic
figur
legend
analysi
sarss
merssdriven
transduct
target
cell
first
transfect
plasmid
encod
respect
order
allow
effici
proteindriven
host
cell
entri
experiment
set
transduct
effici
quantifi
h
post
transduct
determin
luciferas
activ
cell
lysat
use
commerci
avail
beetlejuic
luciferas
kit
pjk
kleinbittersdorf
germani
hidex
plate
chameleon
luminomet
order
investig
impact
spp
inhibitor
activ
recombin
catb
catl
releas
fluorophor
amc
peptid
substrat
zargargamc
catb
catl
determin
use
commerci
avail
kit
innozym
cathepsin
b
l
kit
merck
kgaa
darmstadt
germani
posit
control
inhibit
recombin
catb
catl
zfi
tbu
dmk
use
fluoresc
quantifi
use
hidex
sens
reader
kidney
cell
seed
glass
coverslip
cell
cultur
plate
cellswel
incub
h
subsequ
cell
cotransfect
lipofectamin
invitrogen
carlsbad
usa
plasmid
encod
catb
catl
carri
flagtag
plasmid
encod
late
endosomallysosom
marker
protein
fuse
mscarlet
four
hour
post
transfect
cell
wash
twice
pb
treat
fresh
cultur
medium
contain
proteas
inhibitor
dmso
control
h
post
inhibitor
treatment
glass
coverslip
wash
pb
follow
fixat
paraformaldehyd
min
room
temperatur
rt
follow
wash
three
time
pb
next
glass
coverslip
incub
triton
pb
min
rt
wash
three
time
pb
prepar
antibodi
stain
glass
coverslip
block
min
pb
contain
tween
bovin
serum
albumin
bsa
primari
antibodi
mous
monoclon
antiflag
antibodi
sigmaaldrich
taufenkirchen
germani
dilut
pb
contain
tween
bsa
glass
coverslip
place
upsid
droplet
antibodi
dilut
incub
room
temperatur
h
glass
coverslip
wash
three
time
pb
incub
upsid
droplet
contain
secondari
antibodi
alexa
fluor
donkey
antimous
igg
life
technolog
eugen
usa
dilut
pb
supplement
tween
bsa
room
temperatur
h
dark
glass
coverslip
wash
twice
pb
follow
two
wash
distil
prior
mount
onto
microscop
slide
mowiol
fluoresc
microscopi
perform
zeiss
equip
oil
planapochromat
object
nm
laser
carl
zeiss
microscopi
germani
imag
acquir
x
pixel
size
bit
depth
bit
quantifi
coloc
catb
catl
ten
cell
condit
select
pearson
correl
coeffici
pcc
overlap
catb
catl
signal
specif
signal
singl
cell
determin
use
zeiss
softwar
zen
blue
edit
sole
present
purpos
confoc
imag
color
convert
jpeg
format
crop
origin
size
imag
modif
perform
statist
analys
perform
welch
ttest
transduct
assay
use
microsoft
excel
student
ttest
use
graphpad
prism
coloc
studi
